FDA panel votes down Avastin breast cancer use
June 29, 2011 at 16:13 PM EDT
A Food and Drug Administration advisory panel voted decisively on Wednesday to withdraw approval for Avastin to treat breast cancer.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.